Evidence map›Paper›PMID 36490345›Full record

ArticleScience advances2022

Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions.

Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel R Landau, Eli Rothenberg

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. A variant-dependent molecular clock with anomalous diffusion models SARS-CoV-2 evolution in humans.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shaun M ChristieDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-4741-721X
Takuya TadaDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-0779-9954
Yandong YinDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-2499-871X
Amit BhardwajDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-0755-9507
Nathaniel R LandauDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-9997-1004
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-1382-1380
New York University · US

Funding

Structural determinants of Pol theta functionP01CA247773 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sylvie Doublie · 2020 to 2026
$15.2M
Therapeutic Dendritic Cell Vaccine for HIVDP1DA046100 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LANDAU, NATHANIEL R. · 2018 to 2023
$4.2M
Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging - Equipment SupplementR35GM134947 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Eli Rothenberg · 2020 to 2026
$3.4M
Mechanism and Fidelity of RAG mediated DNA recombinationR01AI153040 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2020 to 2024
$2.7M
Dendritic Cell Vaccine for Controlling the Latent ReservoirR33AI122390 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KIEM, HANS-PETER, KITCHEN, SCOTT G · 2018 to 2020
$1.6M
Lentiviral Vector Vaccine for HIV-1K08AI120898 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NORTON, THOMAS D · 2015 to 2018
$774k
Dendritic Cell Vaccine for Controlling the Latent ReservoirR21AI122390 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KIEM, HANS-PETER, KITCHEN, SCOTT G · 2016 to 2017
$457k
NCI NIH HHS P01 CA247773NIAID NIH HHS K08 AI120898NIAID NIH HHS R01 AI153040NIAID NIH HHS R21 AI122390NIAID NIH HHS R33 AI122390NIDA NIH HHS DP1 DA046100NIGMS NIH HHS R35 GM134947
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a global health crisis after its emergence in 2019. Replication of the virus is initiated by binding of the viral spike (S) protein to human angiotensin-converting enzyme 2 (ACE2) on the target cell surface. Mutations acquired by SARS-CoV-2 S variants likely influence virus-target cell interaction. Here, using single-virus tracking to capture these initial steps, we observe how viruses carrying variant S interact with target cells. Specificity for ACE2 occurs for viruses with the reference sequence or D614G mutation. Analysis of the Alpha, Beta, and Delta SARS-CoV-2 variant S proteins revealed a progressive altered cell interaction with a reduced dependence on ACE2. Notably, the Delta variant S affinity was independent of ACE2. These enhanced interactions may account for the increased transmissibility of variants. Knowledge of how mutations influence cell interaction is essential for vaccine development against emerging variants of SARS-CoV-2.

Indexed as

COVID-19Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2HumansMutationPeptidyl-Dipeptidase AProtein BindingSARS-CoV-2Angiotensin-Converting Enzyme 2Peptidyl-Dipeptidase ASpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36490345
PMCPMC9733935
OpenAlexW4311662899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.